Abstract MP255: Intercellular Model Predicts Macrophage Signaling As A Driver Of Cardiac Fibroblast Response Post Myocardial Infarction

2021 ◽  
Vol 129 (Suppl_1) ◽  
Author(s):  
Mukti Chowkwale ◽  
Jeffrey J Saucerman

Introduction: Post-myocardial infarction (MI), cardiac fibroblasts and macrophages work together to regulate tissue homeostasis and infarct repair. Macrophage-fibroblast interactions in healthy tissue are stable and resistant to perturbations. However, this robustness post-MI has not been assessed. This study designs and implements an intercellular communication model of macrophage-fibroblast crosstalk to determine drivers of infarct repair. Methods: An ordinary differential equation model of post-MI cellular dynamics was developed ( Figure 1A ). Model inputs are time courses of cardiomyocytes, neutrophils, and monocytes. These cells, along with simulated macrophages and fibroblasts, secrete chemokines and cytokines which directed cell proliferation, removal, and chemical secretion. The outputs are macrophage and fibroblast densities, secreted factor dynamics, and produced collagen. Model validation was done using published data in post-MI mice. A sensitivity analysis was conducted by knocking down individual parameters to identify key drivers of fibroblast collagen production. Results: The simulated trends matched the validation time courses. Of the 28 validation relationships, 12 were input-output, 7 were knockouts, and 9 were inhibitor relationships. The validation passed at 78.5%; the 6 failed validations were due to the independent nature of the input curves. Sensitivity analysis ( Figure 1B ) identified macrophage differentiation rate, removal rate, and transforming growth factor-beta (TGFB) secretion rate as pro-fibrotic. Prolonged exposure to TGFB and granulocyte-macrophage colony stimulating factor was anti-fibrotic. Several clustered parameters differentially regulated macrophages and collagen production. Conclusions: The multicellular model identified macrophage density as a pro-fibrotic driver in the healing infarct. Differential regulation of macrophages and collagen production was predicted by the model.

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Toru Miyoshi ◽  
Satoshi Hirohata ◽  
Tadahisa Uesugi ◽  
Minoru Hirota ◽  
Hiromichi Ohnishi ◽  
...  

PURPOSE: Activin A, a member of the transforming growth factor-beta cytokine family, has been suggested to play a role in inflammation and have pleiotropic functions. We examined the alteration of serum activin A level in patients with ST-segment elevation myocardial infarction (STEMI) who received successful primary percutaneous coronary intervention (PCI) within 12 hours, and investigated whether serum activin A was associated with infarct size. METHODS: We examined 26 patients with STEMI, 20 consecutive stable angina pectoris (AP) patients and 20 normal subjects. In STEMI patients, blood samples were collected before PCI (day0) and days 1, 2, 7 and 14. Serum activin A level was measured by enzyme-linked immunoassay. Change of activin A between day 2 and day0 (delta 2d) was also examined. The serum levels of activin A were compared with infarct size, as indicated with peak CK. RESULTS: Patients with STEMI demonstrated significantly higher serum activin A level (before PCI) than control subjects and patients with AP (316±112, 369±153 and 569±272 pg/ml, p<0.001 and p=0.007, respectively). The activin A level was significantly elevated and peaked on day 0 and reduced on days 2, and then gradually increased until days 14. Log-transformed peak CK was significantly correlated with serum activin A level on day0 (r=0.55, p=0.004) and delta 2d (r=0.58, p=0.023). In stepwise analysis, serum activin A level (beta=0.37, p=0.022) as well as age, culprit lesion (LAD) and smoking was an independent predictor of peak CK. CONCLUSIONS: The findings suggest that serum activin A level was elevated in STEMI and it may be associated with infarct size in STEMI patients.


Sign in / Sign up

Export Citation Format

Share Document